Funding hub The SMA Foundation is the leading funder of SMA research globally with substantial grant activity (over $100M spent on research and $30M on tools and assets). This positions them as a premier partner for pharma, biotech, and academic collaborations seeking funding-backed research and access to validated assets.

Shared results A core mandate is to ensure research results are freely available with minimal cost and obligation, enabling partners to leverage findings quickly. This openness can reduce barrier to collaboration and accelerate joint development programs.

Strategic partnerships Recent and ongoing collaborations with industry players (for example, PTC Therapeutics and Roche in past programs; Impulse Partners in 2026) indicate a strong track record of creating co-development opportunities and consulting roles, suggesting a credible path for new joint ventures.

Network broker The Foundation acts as a hub connecting pharma, biotech, academia, clinicians, government/regulators, and media. This network access can be offered as a consultancy or partnership platform to accelerate alliance formation and market entry strategies for potential partners.

Funding readiness With a global reach, notable media recognition, and a blend of nonprofit, VC, and biotech leadership, SMA Foundation can co-create grant-backed pilots, funding programs, or milestone-based partnerships that de-risk early-stage SMA programs for potential buyers or collaborators.